#insulin resistance

1 article

A clean, modern editorial flat-lay on a pale oat-colored linen surface, shot from slightly above in soft diffused natural window light. At the center sits an amber glass supplement bottle with a minimalist cream label, unbranded, with a few capsules spilling onto the fabric in soft greens and ivory tones. Around it are fresh botanical elements: a sprig of green tea leaves, sliced ginger root, a small bundle of dried hibiscus petals, and a few pale green pineapple and papaya slices hinting at digestive enzymes. A small ceramic bowl of creamy plain yogurt with a wooden spoon suggests probiotics. To the left, a flexible tailor's measuring tape in soft blush pink loosely curls across the linen, with a slim brushed-brass scale partly visible at the frame edge. On the right, a minimalist white notebook lies open with a hand-drawn simple line chart showing two diverging lines, one trending downward and one flat, with no readable text. A pair of reading glasses with thin gold frames rests beside it, and a tiny pair of balanced brass scales sits in the background, subtly suggesting weighing evidence and caution.

The palette is muted sage green, warm cream, soft terracotta, and touches of blush and brass. Shadows are gentle and long, the depth of field is shallow with a creamy blurred background, and the negative space on the left third of the frame leaves room for a headline overlay. The overall feel is a contemporary health and science journal, calm, trustworthy, and slightly skeptical, in the style of a premium wellness magazine photographed with a 50mm lens, with crisp texture on linen, glass, and botanicals.

SlimSEB Probiotic-Enzyme Blend Beat Placebo—But There's a Catch

BY DR. GYMBRO · Oct 30, 2026

A probiotic, enzyme and botanical blend called SlimSEB beat placebo in a 12-week randomized trial of 87 adults at risk of type 2 diabetes. Obese participants lost 4.5 kg more than placebo and trimmed their waists by 11 cm, while cholesterol and insulin resistance also improved. But the product was supplied by its maker, the trial was small and short, and the multi-ingredient formula means no single component can take credit. Here is what the data show, how they compare with GLP-1 drugs, and who should think twice.